In order for our site to display correctly you will need a newer version of your web browser.
The following browsers support numerous web standards including CSS,XHTML, and the DOM (a universal means of controlling the behavior of web pages):
- Netscape v7 or higher (all platforms), Mozilla FireFox (Windows), Camino (Mac OS X), Galeon (Linux GNOME Desktop) or other browser stemming from the Mozilla.org project.
- Opera v7 or higher (Windows, Linux)
- Apple's Safari (Mac OS X)
- Konqueror (Linux KDE Desktop)
- Microsoft Internet Explorer v6 or higher (Windows) or v5 or higher (Macintosh)
Please note that this is not intended be an exhaustive list of browsers that support web standards, nor a test of browser compliance, nor a side-by-side comparison of various manufacturers’ browsers.
Finding Cures. Saving Children.
Mondira Kundu, MD, PhD
Assistant Member, St. Jude Faculty
Departments
Pathology
Contact Information
Mondira Kundu, MD, PhD
Pathology
MS 343, Room D-4026C
St. Jude Children's Research Hospital
262 Danny Thomas Place
Memphis, TN 38105-3678
Email: mondira.kundu@stjude.org
Phone: (901) 595-6048
FAX: (901) 595-5947
Education
MD – Jefferson Medical College, Philadelphia, Pennsylvania
PhD – Thomas Jefferson University, Philadelphia, Pennsylvania
Research Interests
My research is motivated by a desire to develop novel insights into the pathogenesis of hematopoietic disorders, including myelodysplastic syndromes and acute leukemias, to guide the development of improved diagnostic tools and therapies. In particular, I would like to understand the molecular mechanisms involved in mitochondrial clearance and determine whether perturbations of this pathway can contribute to hematopoietic malignancies.
- Characterization of signals involved in targeting mitochondria for autophagic degradation
- Role of autophagy in erythropoiesis and tumorigenesis
Selected Publications
Kundu, M, Lindsten, T, Yang C-Y, Wu J, Zhao F, Zhang J, Selak MA, Ney PA, Thompson CB. Ulk1 plays a critical role in the autophagic clearance of mitochondria and ribosomes during reticulocyte maturation. Blood (First Edition Paper, prepublished online June 6, 2008).
Myung, PS, Kundu, M, Abboud, SK. Eosinophilic granuloma manifesting as painless cervical lymphadenopathy in a patient positive for human immunodeficiency virus 1. Arch Otolaryngol Head Neck Surg 134: 203-205, 2008.
Schweers RL, Zhang J, Randall MS, Loyd MR, Li W, Dorsey FC, Kundu M, Opferman JT, Cleveland JL, Miller JL, Ney P. NIX is required for programmed mitochondrial clearance during reticulocyte maturation. Proc Natl Acad Sci U S A 104:19500-5, 2007.
Kundu M, Garrett L, Starost M, Eckhaus M, Speck N, Liu PP. Runx1 deficiency predisposes to T-cell lymphoblastic lymphoma in mice. Blood 106, 3621-3624, 2005.
Kundu M, Liu PP. Cbfb_is involved in maturation of all lineages of hematopoietic cells during embryogenesis except erythroid.Blood Cells, Molecules, and Diseases 30:164-169, 2003.
Kundu M, Javed A, Jeon J-P, Horner A, Shum L, Eckhaus M, Muenke M, Lian JB, Yang Y, Nuckolls G, Stein GS, Liu PP. The hematopoietic transcription factor, CBFb interacts with Runx2 and has a critical role in bone development. Nat Genetics 32:639-644, 2002.
Kundu M, Chen A, Castilla L, Anderson S, Kirby M, Bodine D, Liu PP. Role of Cbfb in hematopoiesis and perturbations resulting from expression of the leukemogenic fusion gene Cbfb-MYH11. Blood 100: 2449-2456, 2002.
Lukasik SM, Zhang L, Corpora T, Tomanicek S, Li Y, Kundu M, Hartman K, Liu PP, Laue TM, Biltonen RL, Speck NA, Bushweller JH. Altered affinity of CBFbeta-SMMHC for Runx1 explains its role in leukemogenesis. Nat Struct Biol. 9: 674-670, 2002.
Darbinian N, Gallia GL, Kundu M, Shcherbik N, Tretiakova A, Gioardano A, Khalili K. Association of Pur-alpha and E2F-1 suppresses transcriptional activity of E2F-1. Oncogene 18: 6398-402, 1999.
Kundu M, Ansari SA, Chepenik LG, Pomerantz RG, Khalili K, Amini S. HIV-1 regulatory protein Tat induces RNA binding proteins in central nervous system cells that associate with the viral trans-acting-response regulatory motif. Human Virology 2: 72-80, 1999.
Kundu M*, Sharma S*, De Luca A, Giordano A, Rappaport J, Khalili K, Amini S. HIV-1 Tat elongates the G1 phase and indirectly promotes HIV-1 gene expression in cells of glial origin. J Biol Chem 273: 8130-8136, 1998. *authors contributed equally
Kundu M, Guerma M, Roeder RG, Khalili K. Interaction between cell cycle regulator, E2F-1, and NF-kappa B mediates repression of the HIV-1 LTR. J Biol Chem 272: 29468-28474, 1997.
Thatikunta P, Raj G, Kundu M, Khalili K, Amini S. The transcription factor E2F-1 modulates TGF-b1 RNA expression in glial cells. Oncogene 14: 2959-2969, 1997.
Kundu M*, Sala A*, Casela I, Engelhard A, Calabretta B, Grasso L, Paggi MG, Giordano A, Watson RJ, Khalili K, Peschle C. Activation of human B-myb by cyclins. Proc Natl Acad Sci USA 94: 532-536, 1996. *authors contributed equally
Kundu M, Srinivasan A, Pomerantz RJ, Khalili K. Evidence that a cell cycle regulator, E2F-1, down-regulates transcriptional activity of the human immunodeficiency virus type 1 promoter. J Virol 69: 6940-6946, 1995.
Taylor JP, Kundu M, Khalili K. TAR-independent activation of HIV-1 requires the activation domain but not the RNA-binding domain of Tat. Virology 195: 780-785, 1993.
Chowdhury M, Kundu M, Khalili K. GA/GC-rich sequence confers Tat responsiveness to human neurotropic virus promoter, JCVL, in cells derived from central nervous system. Oncogene 8: 887-892, 1993.
Last update: July 2008
